RSV Protection Now Available for Seniors and Infants

For the 2025–2026 cold and flu season, the Ontario government has expanded its Respiratory Syncytial Virus (RSV) prevention program to help protect those most at risk of serious illness.

Who is eligible for publicly funded RSV vaccine?

• Older Adults (75+): All individuals aged 75 years and older are now eligible to receive RSV protection.
• Infants and Newborns: Babies born on or after April 1, 2025, and under 8 months of age will be offered nirsevimab (Beyfortus). This may be given at the hospital following birth or at your family doctor’s office.
• Pregnant Individuals: An RSV vaccine (Abrysvo) may be offered between 32–36 weeks of pregnancy to those delivering during RSV season who intend to decline Beyfortus for their newborn.

This program reduces the risk of severe RSV illness for infants and older adults, the groups most vulnerable to complications.

If you have already received Arexvy or Abrysvo, you do not need another dose. 

Please talk to your healthcare provider to see if RSV protection is right for you.